Across rheumatic diseases

The projected burden of arthritis among adults and children in Australia to the year 2040: a population-level forecasting study

Lancet RheumatolPublished Population-level forecasting study

Authors' conclusion

Using the latest national-level data, this study has generated contemporary projections of the substantial burden of arthritis (both population size and health-care costs) in Australia.

Study context

Population
Adults and children in Australia; prevalence from ABS 2022 National Health Survey (arthritis, OA, RA) and 2021 Census (JIA), applied to national population projections for 2025–2040
Outcome
Projected number of people with arthritis, OA, RA and JIA, and associated health system expenditure
Follow-up
2025, 2030, 2035 and 2040
Methodological detailsmedium population growth base case, sensitivity analyses with low and high growth scenarios, consumer researcher review, Arthritis consumer researcher and members of the Arthritis Australia Consumer Advisory Panel reviewed the burden estimates
  • Medium population growth base case
  • Sensitivity analyses with low and high growth scenarios
  • Consumer researcher review
  • Arthritis consumer researcher and members of the Arthritis Australia Consumer Advisory Panel reviewed the burden estimates

Main finding

As reported in the abstract

Projected burden of arthritis in Australia · 2040
People projected to have arthritis in 2040
5.39 million (95% CI 5.19-5.58 million)
People with arthritis in 2025 (3.95-4.27 million)
4.11 million
Increase in arthritis 2025 to 2040
31%
People expected to have OA by 2040 (2.99-3.23 million)
3.11 million
People expected to have RA by 2040 (652 000-846 000)
749 000
Children and adolescents expected to have JIA by 2040 (little change anticipated)
about 8500
Annual health system expenditure for OA and RA by 2040 (conservative forecast; based on AU$2100 per person with OA and $1918 per person with RA)
exceed AU$11.92 billion

Further findings

Age-standardised rate of OA · 2025 to 2040

Males, 2025 to 2040
6.28% to 7.03%
Females, 2025 to 2040
10.82% to 12.18%

Age-standardised rate of RA · 2025 to 2040

Males, 2025 to 2040
1.56% to 1.75%
Females, 2025 to 2040
2.62% to 2.94%

Original publication

The projected burden of arthritis among adults and children in Australia to the year 2040: a population-level forecasting study. Lancet Rheumatol. Published 5 December 2024. doi:10.1016/s2665-9913(24)00247-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.